Rich NE, Oji S, Mufti AR, et al. Racial and ethnic disparities in non-alcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A Meta-Analysis. AASLD 2017, abstract 57.
Europese Commissie keurt risankizumab (Skyrizi) goed voor behandeling matig tot ernstig actieve colitis ulcerosa
okt 2024 | IBD